Experts advise on how country can build sustainable systems ANALYSIS | IAN KATUSIIME | When U.S. President Donald Trump on ...
The South African on MSN22h
HIV trial in SA shows long-term control without daily medsSouth African scientists announce promising results from an HIV cure trial, showing hope for long-term virus control without ...
The Sunday Mail Lincoln Towindo ZIMBABWE has secured an additional three-month’s supply of antiretroviral (ARV) drugs that will ensure current stock levels will last until the end of September, Health ...
Clinical Trials Arena on MSN3d
Arvinas’ PROTAC halves protein suspected to play role in Parkinson’sA first-in-human trial of Arvinas’ investigational Parkinson’s’ disease therapy, ARV-102, has been able to demonstrate a drop ...
Culturally tailored HIV interventions to increase ART adherence in young Black men who have sex with men should address social support and depression.
As of the end of 2023, nearly 40 million people worldwide were living with HIV, including approximately 1.2 million in the ...
Babies born to HIV-positive mothers in Kenya face an increased risk of contracting the virus due to a shortage of critical ...
The study by Sari Reisner and colleagues1 in The Lancet HIV on gender-affirming hormone therapy and its effect on HIV ...
10d
If the past four decades have taught us anything about HIV, it's to adjust our expectations—despite enormous progress in ...
First-in-human study evaluating a novel long-acting injectable antiretroviral therapy provides promising early results on its ...
The future of HIV care requires balancing scientific advancement with practical implementation. Long-acting antiretroviral therapy (ART) has revolutionized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback